Iron acquisition: a novel perspective on mucormycosis pathogenesis and treatment.
about
Iron chelation therapy in myelodysplastic syndromes: where do we stand?Fungal iron availability during deep seated candidiasis is defined by a complex interplay involving systemic and local eventsMucormycosis caused by unusual mucormycetes, non-Rhizopus, -Mucor, and -Lichtheimia speciesAntifungal activity of microbial secondary metabolitesFob1 and Fob2 Proteins Are Virulence Determinants of Rhizopus oryzae via Facilitating Iron Uptake from FerrioxamineAdaptation to thermotolerance in Rhizopus coincides with virulence as revealed by avian and invertebrate infection models, phylogeny, physiological and metabolic flexibilityThe spectrum of fungi that infects humansDelaying diagnostic procedure significantly increases mortality in patients with invasive mucormycosis.The endothelial cell receptor GRP78 is required for mucormycosis pathogenesis in diabetic mice.The high affinity iron permease is a key virulence factor required for Rhizopus oryzae pathogenesisFunctional characterization of the ferroxidase, permease high-affinity iron transport complex from Candida albicansRisk factors associated with invasive fungal infections in combat trauma.Rhinocerebral mucormycosis in a diabetic case report.Comparative pharmacodynamics of posaconazole in neutropenic murine models of invasive pulmonary aspergillosis and mucormycosis.Combat-Related Invasive Fungal Wound InfectionsCandida albicans Hap43 is a repressor induced under low-iron conditions and is essential for iron-responsive transcriptional regulation and virulence.Zygomycosis in Immunocompromised non-Haematological Patients.Host cell invasion in mucormycosis: role of ironHuman Fungal Pathogens of Mucorales and Entomophthorales.Future directions in mucormycosis research.How I treat mucormycosis.A Fatal Outcome of Rhino-orbito-cerebral Mucormycosis Following Tooth Extraction: A Case ReportPredisposing Factors for Mucormycosis in Patients with Diabetes Mellitus; An Experience of 21 Years in Southern Iran.Diagnosis and treatment of mucormycosis in patients with hematological malignancies: guidelines from the 3rd European Conference on Infections in Leukemia (ECIL 3).Bicarbonate correction of ketoacidosis alters host-pathogen interactions and alleviates mucormycosisSynthetic and natural iron chelators: therapeutic potential and clinical useRhino-orbital Mucormycosis: Clinical Findings and Treatment Outcomes of Four Cases.Immunotherapy against invasive mold infections.Pathogenesis of mucormycosis.Safety and efficacy of deferasirox in the management of transfusion-dependent patients with myelodysplastic syndrome and aplastic anaemia: a perspective review.Management of Acute Myeloid Leukemia in the Intensive Care Setting.Mucormycosis in India: unique features.Combination therapy for the treatment of pulmonary mold infections.Breaking the Mold: A Review of Mucormycosis and Current Pharmacological Treatment Options.Higher In vitro Proliferation Rate of Rhizopus oryzae in Blood of Diabetic Individuals in Chronic Glycaemic Control Compared with Non-diabetic Individuals.Rhizopus arrhizus Invasive Infection due to Self-Inflicted Scratch Injuries in a Diabetic Patient with Non-ketotic Acidosis.Management of Pulmonary Mucormycosis Based on a Polymerase Chain Reaction (PCR) Diagnosis in Patients with Hematologic Malignancies: A Report of Four Cases.Looks like Tuberculous Meningitis, But Not: A Case of Rhinocerebral Mucormycosis with Garcin Syndrome.Apophysomyces variabilis: draft genome sequence and comparison of predictive virulence determinants with other medically important Mucorales.Iron overload in patients undergoing hematopoietic stem cell transplantation.
P2860
Q27011747-214E9665-A6FD-43CB-BCD8-439FC5988081Q27332296-716D1335-F846-4DBD-BB7A-C7042AD1D77BQ28389719-688FE114-8A26-4B4A-B8AC-B928454377A5Q28477201-88A70526-3AF2-4D1C-9C36-B255B3F8AE82Q28547234-0AE26C2A-0A90-462F-B0B5-C28C098DF207Q28606369-FC27C4F8-B912-43DB-9326-B8EC81CA58C4Q28652321-69B2A464-4982-43AF-AE61-BDE78DD398E5Q33427532-A5022AAD-9F08-4C19-9937-D48412AE7218Q33882951-4A234DD8-E750-4406-ADEF-029436D94059Q34017347-3282BC01-6A5D-4343-B84F-E9E974E42EE2Q34190117-24E45A4F-ECF8-4D9C-81C5-E049D6DFBDB3Q34329954-7D462E15-9773-447F-918C-22C27147EACCQ34495802-1FCC6105-896A-483A-9045-F14CD1DC596FQ34596761-4378741A-6840-49B1-AD7A-12BE44C7166DQ34708588-A5EAB5CD-FA90-4012-A9AA-C01404F12C9EQ34739217-E263295C-5F20-4009-8F18-858A2F359555Q35010681-5FAD16BE-E266-45FD-98CC-F08A8103D529Q35175555-A3FC1906-1D1A-4870-9421-CDDB6152B46CQ35245238-325D1688-9BA9-4986-930F-F658F3654E19Q35672102-2391B1CF-91B6-48BE-9F7E-72258C91F6D1Q35797637-CDAAEF00-1505-4202-8189-971E9368B7ABQ35892109-40C3F993-12B8-4832-A4D6-FD1456539527Q36681043-721461A7-FDD4-4A44-9705-E8E1E48CFE78Q36862446-0B646FEE-C6FA-4BF2-80CF-CD4D9E8B2CE8Q36951755-6A1F01ED-B782-4C6E-89AA-8F3B57772FD9Q37290073-A585E15C-E28C-4C84-A521-9B6656395FF4Q37370491-408286CC-97C5-464D-85B5-6213DF0374D2Q37965757-CFB40201-ECEA-4B02-AE74-C906370C8558Q37976046-01479E5B-62E6-452E-BDD8-664EF1C4D1C9Q38101043-565D8A12-B85E-4DAC-8A88-2533F92C434DQ38206394-FE3EAF9F-5DC9-40C6-A591-722039A121D6Q38245969-049A880F-AB2F-422D-97F9-A2E002C950DEQ38806932-00549AF2-E66A-4297-821D-41DD4F4880FFQ38866474-BF965A9A-2BCD-45CC-AD5C-D1B5D5FCB9F8Q40132220-D05BD513-128C-4597-80D3-0B0D5784DDB7Q40159963-F8498E6F-DA78-4E63-883A-F8B52FB730E1Q40287118-076B6DD0-AD59-449C-99B1-E4463F2CA294Q40460610-848EB269-DC21-40F0-AE41-E117E3CA7B53Q41704770-3CE695E6-9BA6-49F9-9BB7-F2D3AD1CB6E2Q41914835-FADCB1E2-9DEA-45FB-AD7B-E64C2D2F08E1
P2860
Iron acquisition: a novel perspective on mucormycosis pathogenesis and treatment.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Iron acquisition: a novel perspective on mucormycosis pathogenesis and treatment.
@en
Iron acquisition: a novel perspective on mucormycosis pathogenesis and treatment.
@nl
type
label
Iron acquisition: a novel perspective on mucormycosis pathogenesis and treatment.
@en
Iron acquisition: a novel perspective on mucormycosis pathogenesis and treatment.
@nl
prefLabel
Iron acquisition: a novel perspective on mucormycosis pathogenesis and treatment.
@en
Iron acquisition: a novel perspective on mucormycosis pathogenesis and treatment.
@nl
P2093
P2860
P1476
Iron acquisition: a novel perspective on mucormycosis pathogenesis and treatment.
@en
P2093
Ashraf S Ibrahim
Brad Spellberg
John Edwards
P2860
P304
P356
10.1097/QCO.0B013E3283165FD1
P577
2008-12-01T00:00:00Z